News and Updates

Aurobindo Pharma shares rise 2% after clearing a rigorous USFDA inspection. Learn how this regulatory success impacts the company's manufacturing outlook.

New research explores how Low-Level Laser Therapy (LLLT) accelerates dental implant osseointegration and improves peri-implant clinical health outcomes.

Explore the July 2026 clinical trial recruiting trends. Learn how protocol design, AI, and patient-centric strategies are shaping the future of enrollment.

The US FDA has granted a Voluntary Action Indicated (VAI) status to Aurobindo Pharma's Raleigh unit. Learn what this classification means for the facility.

Researchers are testing if lidocaine can lower inflammation after heart bypass surgery. Discover how this common drug may reduce post-op risks.

AbelZeta regains global rights to C-CAR039 and receives FDA IND clearance for trials in Large B-cell Lymphoma, marking a major step in CAR-T innovation.

ArkBio has launched a US Phase II trial for Ziresovir, a novel antiviral treatment targeting severe RSV in infants. Discover the potential clinical impact.

Are AI decision support tools moving faster than the evidence? Explore the critical validation gap threatening patient safety in modern clinical settings.

San Diego’s Aizen Therapeutics secures a $100M-per-target deal to pioneer innovative peptide-based drugs. Discover what this means for precision medicine.

Meant debuts a LegitScript-certified GLP-1 telehealth platform, prioritizing safe, clinician-led weight management paired with professional coaching.